NB QHDM venture foundry · identity review
NEUBRIX
Name and public offer paused.
An exact-name medical technology was identified in an overlapping field. QHDM has paused promotion, research solicitation, domain investment and search indexing while identity and rights risks are reviewed.
- Public stage
- Paused
- Domain action
- Do not renew or promote
- Partner intake
- Suspended
- Reactivation gate
- Documented name-clearance decision
Risk hold
No public NEUBRIX activity is being solicited.
- No research or design-partner intake
- No consumer, clinical or medical-device claims
- No affiliate, advertising or domain spend
- No inference of trademark clearance or affiliation with third parties